Viela Bio: Viela Bio closes $3.1B sale to European pharmaceutical company
The Gaithersburg drug developer agreed to sell for $3.1 billion.
Read full article »
Viela Bio is a Maryland-based biotechnology company that develops and commercializes therapeutics for autoimmune and severe inflammatory diseases.
Read more